PAR-23-216: Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants to colleges and universities. Applications closed on September 30, 2025.
From the official notice on Grants.gov, last changed July 11, 2023. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP30
- Clinical trialsOptional
- Funded byNIGMS
- Median yearly award$450,690
- Typical project length5 years
- P30, Center Core Grant. Shared facilities and services for investigators who already hold research funding on a common theme. Other open P30 notices.
Projects funded under PAR-23-216 were run by National Institute of General Medical Sciences (NIGMS, 26 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-23-216 in the NIH Guide.
Key dates
| Posted | July 11, 2023 |
|---|---|
| Deadline | September 30, 2025 |
| Archived by Grants.gov | November 5, 2025 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details
Is this a realistic fit?
- Most of the program's money (80% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this Notice of Funding Opportunity (NOFO) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.
Funded under PAR-23-216 so far
NIH funded 26 projects under PAR-23-216 in fiscal 2024 to 2026, at 22 institutions. The median yearly award was $450,690.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Movement Analysis Research Core (MOVAN) | University of Nebraska Omaha | 2026 | $321,232 |
| Rodent Behavior Core | West Virginia University | 2026 | $301,121 |
| Administrative Core, Center for American Indian and Rural Health Excellence (CAIRHE) | Montana State University - Bozeman | 2026 | $773,749 |
| Administrative Core | University of North Dakota | 2026 | $455,781 |
| Liver Translational Research and Analytic Core (L-TRAC) | University of Louisville | 2026 | $307,753 |
| COBRE for Restoration of Neural-Based Function | Medical University of South Carolina | 2026 | $1.1 million |
| Center for Childhood Obesity Prevention | Arkansas Children's Hospital Res Inst | 2026 | $1.2 million |
| Research Administration and Mentoring Core (RAMC) | Dartmouth College | 2026 | $449,383 |
Who has won Biomedical Research and Research Training grants before
From fiscal 2021 to 2025, Biomedical Research and Research Training (93.859) awarded $15 billion across 11,631 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Leland Stanford Junior University | California | 186 | $290 million |
| Regents of the University of Michigan | Michigan | 226 | $268 million |
| University of California, San Diego | California | 198 | $264 million |
| Yale Univ | Connecticut | 195 | $250 million |
| University of Wisconsin System | Wisconsin | 169 | $241 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-23-216 still open?
No. It closed on September 30, 2025.
Who can apply for Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)?
Closed September 30, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-23-216?
NIH RePORTER lists 26 projects funded under PAR-23-216 in fiscal 2024 to 2026, at 22 institutions. The most were at University of North Dakota, University of Nebraska Lincoln, University of Delaware.
Who has won Biomedical Research and Research Training grants before?
The largest recipients over five fiscal years were The Leland Stanford Junior University, Regents of the University of Michigan, University of California, San Diego. The program made 11,631 awards worth $15 billion in that time.
Similar open grants
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
- AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)